Lord's Mark Hits 153 US FDA Listings, Boosting Global Reach

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Lord's Mark Hits 153 US FDA Listings, Boosting Global Reach
Overview

Lord's Mark Industries has secured US FDA registration for 153 orthosurgical products, a significant milestone for an Indian medical device manufacturer. This achievement, stemming from its integrated manufacturing ecosystem, boosts the company's access to regulated international markets, including the US, Latin America, and the Middle East, reinforcing India's standing in the global medtech sector.

Lord's Mark Industries Ltd has achieved a significant milestone, securing US Food and Drug Administration (FDA) registration for 153 of its orthosurgical products. This marks one of the largest clearances obtained by an Indian medical device manufacturer, cementing the company's global credentials.

Manufacturing Prowess

These 153 products are manufactured entirely within Lord's Mark Industries' globally aligned production ecosystem. The facilities adhere to internationally benchmarked protocols, supported by robust quality management systems and validated processes. This compliance framework is specifically aligned with US FDA requirements, underscoring the company's commitment to building export-ready, world-class medical manufacturing capabilities in India from its Silvassa base.

Product Portfolio Depth

The US FDA-listed portfolio demonstrates considerable breadth and depth. It encompasses a wide array of orthosurgical items including orthopaedic braces, spinal and cervical supports, knee and ankle braces, compression stockings, hernia belts, and cervical collars. The range also includes specialized items like disinfectant wipes, elastic adhesive bandages, abdominal supports, and post-surgical rehabilitation products, showcasing the company's diverse manufacturing expertise.

Strategic Market Access

This extensive FDA approval significantly strengthens Lord's Mark Industries' access to highly regulated international markets. Opportunities are now amplified in the United States, Latin America, and the Middle East. As global healthcare systems increasingly seek cost-effective yet compliant orthopaedic solutions, the company is strategically positioned to expand institutional supplies, foster hospital partnerships, and grow distributor-led exports.

Leadership Vision and India's Medtech Role

"This milestone goes beyond regulatory recognition. It reinforces our belief that world-class medical devices can be designed, manufactured, and regulated from India at global scale," stated Sachidanand Upadhyay, Managing Director. He highlighted the strength of the Silvassa manufacturing platform and regulatory discipline in positioning India as a trusted source for globally compliant healthcare solutions. Through its US-based subsidiary, Lord's Mark Global LLC, the company further reinforces India's growing presence in the global medtech value chain.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.